The complexity of the association between maternal behavioral differences and these neuropeptidergic mechanisms is exaggerated by the findings that the administration of an Avpr1a antagonist reduces anxiety/depression-like behavior in preclinical studies (Wigger et al., 2004). The gene discussed is AVPR1A; the disease is depressive symptom measurement.